The Tumor Microenvironment Niche of Type I conventional Dendritic Cells

NIH RePORTER · NIH · R01 · $76,956 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY This study investigates the ‘reactive’ immune system in tumors, namely the cellular and molecular allies that allow immunotherapies to work. In particular it studies cells called ‘cDC1’. The overall hypothesis of this proposal is that a molecule called Granulin functions to regulate immunity in tumors, through its expression in these cells. This program is unique in applying spatial transcriptomics together with genetic tools and conventional cellular immunoassay methods to understand the critical phenotype-biology relationship between critical cDC populations and their partners. The resultant discoveries will be formative for designing new ways to boost anti- tumor immunity.

Key facts

NIH application ID
11064353
Project number
3R01CA197363-07S1
Recipient
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Principal Investigator
MATTHEW F KRUMMEL
Activity code
R01
Funding institute
NIH
Fiscal year
2024
Award amount
$76,956
Award type
3
Project period
2023-06-21 → 2028-05-31